Foreword |
|
xi | |
|
|
1 | (14) |
|
1.1 What is a WHO guideline? |
|
|
1 | (1) |
|
1.2 Why does WHO develop guidelines? |
|
|
1 | (1) |
|
1.3 What principles underlie WHO guidelines? |
|
|
1 | (1) |
|
1.4 What is the aim of this handbook? |
|
|
2 | (1) |
|
1.5 For whom Is this handbook Intended? |
|
|
3 | (1) |
|
1.6 What is in this handbook? |
|
|
3 | (1) |
|
1.7 Types of WHO guidelines |
|
|
3 | (6) |
|
1.7.1 Standard guidelines |
|
|
6 | (1) |
|
1.7.2 Consolidated guidelines |
|
|
6 | (1) |
|
|
7 | (1) |
|
1.7.4 Guidelines in response to an emergency or urgent need |
|
|
8 | (1) |
|
1.8 Additional types of guidelines produced by WHO |
|
|
9 | (2) |
|
1.8.1 Guidelines developed in collaboration with external organizations |
|
|
9 | (1) |
|
1.8.2 Guidelines developed by external organizations |
|
|
10 | (1) |
|
1.8.3 Adaptation of existing WHO guidelines |
|
|
10 | (1) |
|
1.9 Information products that are not considered guidelines |
|
|
11 | (1) |
|
1.10 The Guideline Review Committee |
|
|
11 | (2) |
|
1.10.1 Terms of reference of the GRC |
|
|
12 | (1) |
|
1.10.2 The GRC Secretariat |
|
|
13 | (1) |
|
|
13 | (2) |
|
|
15 | (8) |
|
2.1 Is this guideline really needed? |
|
|
15 | (1) |
|
2.1.1 Who wants the guideline? |
|
|
15 | (1) |
|
2.1.2 Should WHO be the organization to produce this guideline? |
|
|
15 | (1) |
|
2.1.3 Do guidelines on the topic already exist? |
|
|
16 | (1) |
|
2.2 What purpose and audience does the guideline serve? |
|
|
16 | (1) |
|
2.2.1 What will the guideline achieve? |
|
|
16 | (1) |
|
2.2.2 What are the specific objectives of the guideline? |
|
|
16 | (1) |
|
2.2.3 Who is the target audience? |
|
|
17 | (1) |
|
2.2.4 Who are the recipients of the interventions? |
|
|
17 | (1) |
|
2.3 When Is the guideline needed? |
|
|
17 | (1) |
|
|
17 | (1) |
|
2.3.2 When is the guideline needed? |
|
|
17 | (1) |
|
2.3.3 Is the guideline a response to a situation calling for urgent advice? |
|
|
18 | (1) |
|
2.4 Will the recommendations in the guideline be implemented? |
|
|
18 | (1) |
|
2.4.1 Are the guideline and its implementation within the relevant programme's work area and budget? |
|
|
18 | (1) |
|
2.4.2 Is a process for disseminating and implementing the recommendations in place? |
|
|
18 | (1) |
|
2.5 Who should be Involved In developing a guideline? |
|
|
19 | (1) |
|
2.5.1 Do you have your director's agreement? |
|
|
19 | (1) |
|
2.5.2 What WHO departments must be involved? |
|
|
19 | (1) |
|
2.5.3 Have you identified experts in guideline methods? |
|
|
19 | (1) |
|
2.6 Additional considerations |
|
|
19 | (1) |
|
2.6.1 Do you have the necessary resources to develop a guideline? |
|
|
20 | (1) |
|
2.6.2 What publication types and formats are you considering? |
|
|
20 | (1) |
|
2.6.3 What translations are you planning? |
|
|
20 | (1) |
|
2.7 Scoping the guideline |
|
|
20 | (2) |
|
2.7.1 How to scope the guideline |
|
|
21 | (1) |
|
|
22 | (1) |
|
3 Contributors and their role in guideline development |
|
|
23 | (16) |
|
|
23 | (1) |
|
3.2 The guideline development group |
|
|
24 | (4) |
|
3.2.1 Composition of the guideline development group |
|
|
25 | (3) |
|
3.3 The external review group |
|
|
28 | (1) |
|
3.4 The systematic review team |
|
|
29 | (4) |
|
3.5 Other individuals and groups involved in guideline development |
|
|
33 | (1) |
|
3.5.1 The guideline methodologist |
|
|
33 | (1) |
|
3.5.2 Consultants with additional technical expertise |
|
|
33 | (1) |
|
3.5.3 Observers at the meeting of the guideline development group |
|
|
33 | (1) |
|
3.5.4 Designated writer/editor |
|
|
34 | (1) |
|
3.6 Funders of the guideline |
|
|
34 | (1) |
|
3.7 Identifying and managing conflicts of interests |
|
|
34 | (1) |
|
3.8 Managing an effective guideline development group meeting |
|
|
35 | (1) |
|
3.8.1 The role of the chair and vice-chair |
|
|
35 | (1) |
|
3.8.2 Decision-making in the guideline development group |
|
|
35 | (1) |
|
3.9 Planning an effective meeting |
|
|
36 | (2) |
|
3.9.1 Goals of the meeting |
|
|
36 | (1) |
|
3.9.2 Preparing for the meeting |
|
|
36 | (1) |
|
3.9.3 Roles and process at the meeting |
|
|
37 | (1) |
|
3.9.4 Follow-up after the meeting |
|
|
37 | (1) |
|
|
38 | (1) |
|
4 Preparing the planning proposal |
|
|
39 | (6) |
|
4.1 What is a guideline planning proposal? |
|
|
39 | (1) |
|
4.2 What Is the purpose of the planning proposal? |
|
|
39 | (1) |
|
4.3 Who develops the planning proposal? |
|
|
40 | (1) |
|
4.4 When should the planning proposal be developed and finalized? |
|
|
41 | (1) |
|
4.5 Preparing the planning proposal |
|
|
41 | (2) |
|
4.6 What if there are major changes In scope or approach after the GRC has approved the planning proposal? |
|
|
43 | (1) |
|
4.7 For how long is an approved planning proposal in effect? |
|
|
44 | (1) |
|
5 Incorporating equity, human rights, gender and social determinants into guidelines |
|
|
45 | (12) |
|
5.1 Reflecting WHO's values in Its guidelines |
|
|
45 | (1) |
|
|
45 | (5) |
|
|
46 | (1) |
|
|
46 | (1) |
|
5.2.3 Social determinants of health and health inequities |
|
|
47 | (1) |
|
|
47 | (1) |
|
5.2.5 Social determinants of health |
|
|
47 | (3) |
|
5.3 Eight entry points for integrating equity, human rights, gender and the social determinants of health into WHO guidelines |
|
|
50 | (1) |
|
5.4 Incorporating equity, human rights, gender and social determinants into each step in guideline development |
|
|
50 | (4) |
|
|
50 | (2) |
|
5.4.2 Phase 2: development |
|
|
52 | (1) |
|
5.4.3 Phase 3: publishing and updating |
|
|
53 | (1) |
|
|
54 | (3) |
|
6 Declaration and management of interests |
|
|
57 | (20) |
|
6.1 What is a conflict of interest? |
|
|
57 | (1) |
|
6.2 What types of conflicts of interest exist? |
|
|
58 | (1) |
|
6.3 Why is a conflict of interest important in guideline development at WHO? |
|
|
59 | (1) |
|
6.4 What are WHO's policies on conflicts of Interest? |
|
|
59 | (1) |
|
6.5 Who should complete a declaration of Interests form? |
|
|
60 | (3) |
|
6.6 What interests need to be disclosed? |
|
|
63 | (1) |
|
6.7 Collecting declarations of interests |
|
|
64 | (1) |
|
6.8 Assessing declarations of interest |
|
|
64 | (3) |
|
6.9 Managing conflicts of Interest at the Individual level |
|
|
67 | (3) |
|
6.9.1 Guideline development group members |
|
|
67 | (2) |
|
|
69 | (1) |
|
6.10 Managing conflicts of interest at the group level |
|
|
70 | (3) |
|
6.10.1 Minimizing the risk posed by conflicts of interest when constituting guideline development groups |
|
|
70 | (2) |
|
6.10.2 Minimizing the risk posed by conflicts of interest during the guideline development process |
|
|
72 | (1) |
|
6.11 Reporting declarations of Interest in the guideline |
|
|
73 | (1) |
|
6.12 What sources of funding are appropriate for WHO guidelines? |
|
|
74 | (1) |
|
|
74 | (3) |
|
7 Formulating questions and selecting outcomes |
|
|
77 | (16) |
|
|
77 | (2) |
|
7.1.1 Background questions |
|
|
77 | (1) |
|
7.1.2 Foreground or key questions |
|
|
78 | (1) |
|
7.2 Formulating key questions in PICO format |
|
|
79 | (4) |
|
|
79 | (1) |
|
7.2.2 Intervention or exposure |
|
|
80 | (1) |
|
|
81 | (1) |
|
|
81 | (1) |
|
7.2.5 Examples of key questions in PICO format |
|
|
82 | (1) |
|
7.3 Types of key questions |
|
|
83 | (3) |
|
7.4 Broadly- versus narrowly-focused key questions |
|
|
86 | (1) |
|
7.5 Number of key questions |
|
|
87 | (1) |
|
7.6 Selecting and rating outcomes |
|
|
87 | (2) |
|
7.7 Finalizing the key questions and priority outcomes |
|
|
89 | (2) |
|
Step 1 Generate an initial list of questions |
|
|
89 | (1) |
|
Step 2 Draft the key questions in PICO format |
|
|
89 | (1) |
|
Step 3 List relevant outcomes |
|
|
89 | (1) |
|
|
89 | (2) |
|
Step 5 Prioritize the key questions |
|
|
91 | (1) |
|
Step 6 Rates the outcomes |
|
|
91 | (1) |
|
Step 7 Finalize the key questions and the important and critical outcomes |
|
|
91 | (1) |
|
|
91 | (1) |
|
|
92 | (1) |
|
8 Evidence retrieval and synthesis |
|
|
93 | (16) |
|
8.1 What is a systematic review? |
|
|
93 | (1) |
|
8.2 Identifying and evaluating existing systematic reviews |
|
|
94 | (3) |
|
8.2.1 Sources for existing systematic reviews |
|
|
94 | (1) |
|
8.2.2 Is a new systematic review needed? |
|
|
95 | (1) |
|
8.2.3 Evaluating the relevance and quality of existing systematic reviews |
|
|
96 | (1) |
|
8.3 Steps in performing a systematic review |
|
|
97 | (6) |
|
Step 1 Develop and finalize the key questions and the study eligibility criteria |
|
|
98 | (1) |
|
Step 2 Identify information sources and search for original articles |
|
|
99 | (2) |
|
Step 3 Select studies and abstract data |
|
|
101 | (1) |
|
Step 4 Assess risk of bias of the individual studies |
|
|
101 | (1) |
|
Step 5 Synthesize and report the results and conclusions |
|
|
102 | (1) |
|
Step 6 Prepare the final report of the systematic review |
|
|
103 | (1) |
|
8.4 Including qualitative research |
|
|
103 | (1) |
|
8.5 Including other types of data In the systematic review |
|
|
104 | (1) |
|
8.6 Updating existing systematic reviews |
|
|
104 | (1) |
|
8.7 How to commission a systematic review |
|
|
105 | (1) |
|
8.8 Systematic review quality standards |
|
|
106 | (1) |
|
8.9 Systematic review reporting standards |
|
|
106 | (1) |
|
|
106 | (3) |
|
|
109 | (14) |
|
9.1 What Is the "quality of the evidence"? |
|
|
110 | (1) |
|
9.2 What are GRADE evidence profiles? |
|
|
110 | (1) |
|
9.3 Who performs the quality assessment? |
|
|
110 | (2) |
|
9.4 What is the role of WHO staff in assessing the quality of the evidence? |
|
|
112 | (1) |
|
9.5 How is the quality of the body of evidence assessed for intervention studies? |
|
|
112 | (8) |
|
9.5.1 Five factors can lower the quality of the body of evidence for each outcome |
|
|
113 | (6) |
|
9.5.2 Three factors can increase the quality of the evidence from observational studies |
|
|
119 | (1) |
|
9.6 How Is the overall quality of the evidence determined? |
|
|
120 | (1) |
|
9.7 Is GRADE applicable In all situations? |
|
|
121 | (1) |
|
|
121 | (2) |
|
10 Developing recommendations |
|
|
123 | (10) |
|
10.1 Factors that determine the direction and strength of recommendations |
|
|
123 | (2) |
|
10.2 Detailed criteria that should be considered when moving from evidence to recommendations |
|
|
125 | (3) |
|
10.2.1 Quality of the evidence |
|
|
125 | (1) |
|
10.2.2 Values and preferences |
|
|
125 | (1) |
|
10.2.3 Balance of benefits and harms |
|
|
126 | (1) |
|
10.2.4 Resource implications |
|
|
126 | (1) |
|
10.2.5 Priority of the problem |
|
|
127 | (1) |
|
10.2.6 Equity and human rights |
|
|
127 | (1) |
|
|
127 | (1) |
|
|
128 | (1) |
|
10.3 Evidence-to-recommendation tables |
|
|
128 | (1) |
|
10.4 The strength of the recommendation |
|
|
128 | (2) |
|
10.4.1 Strong recommendations |
|
|
129 | (1) |
|
10.4.2 Conditional or weak recommendations |
|
|
129 | (1) |
|
10.5 Formulating recommendations |
|
|
130 | (1) |
|
10.5.1 Reaching agreement on recommendations |
|
|
130 | (1) |
|
10.6 Writing recommendations |
|
|
130 | (1) |
|
10.7 When not to make recommendations |
|
|
131 | (1) |
|
|
132 | (1) |
|
11 Rapid advice guidelines in the setting of a public health emergency |
|
|
133 | (24) |
|
11.1 What is a rapid advice guideline? |
|
|
133 | (1) |
|
11.2 What is a rapid review? |
|
|
133 | (1) |
|
11.3 What is the evidence on the validity and impact of rapid reviews and rapid advice guidelines? |
|
|
134 | (1) |
|
11.4 Is a rapid advice guideline needed? |
|
|
134 | (3) |
|
11.4.1 What is the type of emergency and the risk to public health? |
|
|
135 | (1) |
|
11.4.2 Is the event novel? |
|
|
135 | (1) |
|
11.4.3 Does uncertainty need to be urgently addressed? |
|
|
136 | (1) |
|
11.4.4 What is the anticipated time frame for the event? |
|
|
136 | (1) |
|
11.4.5 Will the rapid advice guideline be rapidly implemented? |
|
|
136 | (1) |
|
11.5 How is a rapid advice guideline developed? |
|
|
137 | (4) |
|
11.5.1 Consult the GRC Secretariat early |
|
|
137 | (1) |
|
11.5.2 Formulate the various groups involved in guideline development |
|
|
137 | (3) |
|
11.5.3 Scope the rapid advice guideline and define the key questions |
|
|
140 | (1) |
|
11.5.4 Prepare the planning proposal for the GRC |
|
|
140 | (1) |
|
11.6 How do rapid reviews compare with systematic reviews? |
|
|
141 | (2) |
|
11.6.1 Types of rapid reviews |
|
|
141 | (2) |
|
11.7 Steps in the rapid review process |
|
|
143 | (7) |
|
11.7.1 Select the types of evidence to be collected and identify the appropriate sources |
|
|
143 | (1) |
|
11.7.2 Develop search strategies |
|
|
143 | (1) |
|
11.7.3 Search for grey literature |
|
|
144 | (1) |
|
11.7.4 Common search restrictions |
|
|
144 | (1) |
|
11.7.5 Other strategies for identifying relevant literature |
|
|
145 | (1) |
|
11.7.6 Screening and study selection |
|
|
146 | (1) |
|
11.7.7 Use a stepwise approach with emphasis on higher levels of evidence |
|
|
146 | (1) |
|
11.7.8 Obtaining publications |
|
|
146 | (1) |
|
11.7.9 Data extraction and evidence synthesis |
|
|
147 | (1) |
|
11.7.10 Assess the risk of bias at the individual study level |
|
|
147 | (1) |
|
11.7.11 Evidence synthesis |
|
|
147 | (1) |
|
11.7.12 Assessing the quality of the body of evidence using GRADE |
|
|
148 | (2) |
|
11.8 The rapid review report |
|
|
150 | (1) |
|
11.9 Formulate recommendations |
|
|
151 | (1) |
|
11.9.1 Convene the meeting of the guideline development group |
|
|
151 | (1) |
|
11.9.2 Evidence to recommendations |
|
|
152 | (1) |
|
11.10 Draft the guideline document |
|
|
152 | (1) |
|
11.11 External peer review |
|
|
152 | (1) |
|
11.12 Implementation and the Importance of context |
|
|
153 | (1) |
|
|
153 | (1) |
|
|
154 | (1) |
|
11.15 Guideline Review Committee processes for rapid advice guidelines |
|
|
154 | (1) |
|
|
155 | (1) |
|
|
156 | (1) |
|
12 Producing and publishing the guideline |
|
|
157 | (8) |
|
|
157 | (1) |
|
|
158 | (1) |
|
12.3 The production process |
|
|
159 | (2) |
|
|
159 | (1) |
|
12.3.2 Legal advice on proprietary products |
|
|
160 | (1) |
|
12.3.3 Editing and proofreading |
|
|
160 | (1) |
|
12.3.4 Executive clearance and approval by the Guideline Review Committee |
|
|
160 | (1) |
|
|
160 | (1) |
|
|
161 | (1) |
|
12.4 Disseminating guidelines |
|
|
161 | (2) |
|
12.4.1 Online publication |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
|
162 | (1) |
|
12.4.5 Other forms of dissemination |
|
|
162 | (1) |
|
|
163 | (1) |
|
|
163 | (1) |
|
12.5.2 Updating recommendations |
|
|
163 | (1) |
|
12.5.3 Guidelines that are near or beyond their "review-by" date |
|
|
163 | (1) |
|
12.5.4 Recommendations that may be out of date |
|
|
164 | (1) |
|
|
164 | (1) |
|
13 Adaptation, implementation and evaluation |
|
|
165 | |
|
|
165 | (1) |
|
|
166 | (1) |
|
13.3 Monitoring and evaluation |
|
|
166 | (1) |
|
|
167 | |